Known as seeding trials, these studies prioritize marketing over science while disguising their commercial purpose as legitimate research. Pharmaceutical companies use them to familiarize physicians ...
The Rockville, Maryland-based company said it had a loss of 4 cents per share. Earnings, adjusted for amortization costs and stock option expense, were 59 cents per share. The drugmaker posted revenue ...
From radiation oncology partnerships in Alabama to a $1.1 billion retina acquisition, the physician deal landscape has been anything but quiet this spring. In just 40 days, 15 major transactions ...
LACENTA (Los Angeles Center for Ear, Nose, Throat and Allergy) is setting a new standard in treatment for patients with smell and nasal disorders. Dr. Geoffrey Trenkle, a board-certified ENT surgeon, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results